This inventor holds 1 USPTO granted patent. Top assignee: Actelion Pharmaceuticals Ltd. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Johanna Colvin Riesen: Innovator in Pulmonary Arterial Hypertension Treatment
Introduction
Johanna Colvin Riesen is a notable inventor based in Titusville, NJ (US). She has made significant contributions to the field of medicine, particularly in the treatment of pulmonary arterial hypertension. Her innovative approach has led to the development of methods that enhance patient care and treatment outcomes.
Latest Patents
Johanna holds 1 patent for her work titled "Transitioning patients treated for pulmonary arterial hypertension to selexipag." This patent outlines methods for transitioning patients from a non-selexipag prostacyclin pathway agent to selexipag, providing a new avenue for effective treatment.
Career Highlights
Johanna is currently employed at Actelion Pharmaceuticals Ltd., where she continues to advance her research and development efforts. Her work is pivotal in improving therapeutic strategies for patients suffering from pulmonary arterial hypertension.
Collaborations
Johanna collaborates with esteemed colleagues, including Brian Hartline and Mehul Bipinchandra Shah. These partnerships enhance her research and contribute to the innovative solutions being developed in her field.
Conclusion
Johanna Colvin Riesen exemplifies the spirit of innovation in the medical field, particularly in the treatment of pulmonary arterial hypertension. Her contributions are vital for improving patient outcomes and advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile